Bruce Redding   Executive Vice President, Dermisonics Inc.

Dermisonics Inc. is a drug delivery system company. It is engaged in developing non-invasive, programmable active transdermal drug delivery system.

 
The company’s technology represents an active transdermal drug delivery process by which drugs can be transported through the skin by applying 

 
a low-level ultrasonic wave. The company operates in the Unites States and is headquartered in Irvine, California. http://www.acorda.com/   Video: New York, 2005